Home / Publications / Bicyclic isothioureas for conjugation with tubulin targeted anticancer agents

Bicyclic isothioureas for conjugation with tubulin targeted anticancer agents

Alexander Aleksandrovich Alexeev 1
Alexander Aleksandrovich Alexeev
Evgeniya Vladimirovna Nurieva 1
Evgeniya Vladimirovna Nurieva
Ilia Andreevich Elisseev 1
Ilia Andreevich Elisseev
Konstantin Alexandrovich Lyssenko
Ol'ga Nikolaevna Zefirova 1
Ol'ga Nikolaevna Zefirova
Published 2022-10-21
CommunicationVolume 32, Issue 6, 766-768
0
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Alexeev A. A. et al. Bicyclic isothioureas for conjugation with tubulin targeted anticancer agents // Mendeleev Communications. 2022. Vol. 32. No. 6. pp. 766-768.
GOST all authors (up to 50) Copy
Alexeev A. A., Nurieva E. V., Elisseev I. A., Milaeva E. R., Lyssenko K. A., Zefirova O. N. Bicyclic isothioureas for conjugation with tubulin targeted anticancer agents // Mendeleev Communications. 2022. Vol. 32. No. 6. pp. 766-768.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2022.11.019
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.11.019
TI - Bicyclic isothioureas for conjugation with tubulin targeted anticancer agents
T2 - Mendeleev Communications
AU - Alexeev, Alexander Aleksandrovich
AU - Nurieva, Evgeniya Vladimirovna
AU - Elisseev, Ilia Andreevich
AU - Milaeva, Elena Rudol'fovna
AU - Lyssenko, Konstantin Alexandrovich
AU - Zefirova, Ol'ga Nikolaevna
PY - 2022
DA - 2022/10/21
PB - Mendeleev Communications
SP - 766-768
IS - 6
VL - 32
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Alexeev,
author = {Alexander Aleksandrovich Alexeev and Evgeniya Vladimirovna Nurieva and Ilia Andreevich Elisseev and Elena Rudol'fovna Milaeva and Konstantin Alexandrovich Lyssenko and Ol'ga Nikolaevna Zefirova},
title = {Bicyclic isothioureas for conjugation with tubulin targeted anticancer agents},
journal = {Mendeleev Communications},
year = {2022},
volume = {32},
publisher = {Mendeleev Communications},
month = {Oct},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.11.019},
number = {6},
pages = {766--768},
doi = {10.1016/j.mencom.2022.11.019}
}
MLA
Cite this
MLA Copy
Alexeev, Alexander Aleksandrovich, et al. “Bicyclic isothioureas for conjugation with tubulin targeted anticancer agents.” Mendeleev Communications, vol. 32, no. 6, Oct. 2022, pp. 766-768. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.11.019.

Keywords

annulated bicyclic isothiourea
colchicine
Cyclization
non-aromatic heterocycles
Podophyllotoxin
thioureas
tubulin
zwitterions

Abstract

Two bicyclic annulated isothiourea derivatives were synthesized using as a key stage either the reaction of isothiocyanate halide with sodium sulfide or cyclization of unsaturated thiourea in the presence of bromine. X-ray molecular structure of N-[(3aSR,7aRS,Z)-hexahydro-1,3-benzothiazol-2(3H)-ylidene]glycine was determined. The conjugate of colchicine with [(3aR,5S,6aS)-2-(tert-butylamino)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]thiazol-5-yl]methanol obtained demonstrated pronounced cytotoxic effect on cancer cells.

References

1.
Cyclic Isothiourea in Drug Design
Nurieva E.V., Alexeev A.A., Zefirova O.N.
Chemistry of Heterocyclic Compounds, 2021
2.
Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents
Wu G., Xu B., Yang Y., Zhang X., Fang K., Ma T., Wang H., Xue N., Chen M., Guo W., Jia X., Wang P., Lei H.
European Journal of Medicinal Chemistry, 2018
3.
Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation
Han H., Lin H., He D., Ren Y., Sun W., Liang L., Du M., Li D., Chu Y., Yang M., Wang X., Yang Y.
Chemistry and Biodiversity, 2018
4.
Design, synthesis and anti-cancer evaluation of novel podophyllotoxin derivatives as potent tubulin-targeting agents
Hu C., Zhu X., Wang G., Wu X., Han H., Lu G., Qi J., Pang Y., Yang R., Wang X., Yang Y.
Medicinal Chemistry Research, 2017
5.
Novel Analogue of Colchicine Induces Selective Pro-Death Autophagy and Necrosis in Human Cancer Cells
Larocque K., Ovadje P., Djurdjevic S., Mehdi M., Green J., Pandey S.
PLoS ONE, 2014
7.
Novel colchicine conjugate with unusual effect on the microtubules of cancer cells
Zefirova O.N., Nurieva E.V., Wobith B., Schulz S., Zefirov N.A., Kuznetsov S.A.
Pure and Applied Chemistry, 2020
8.
Azides Derived from Colchicine and their Use in Library Synthesis: a Practical Entry to New Bioactive Derivatives of an Old Natural Drug
Nicolaus N., Zapke J., Riesterer P., Neudörfl J., Prokop A., Oschkinat H., Schmalz H.
ChemMedChem, 2010
9.
10.1016/j.mencom.2022.11.019_b0045
Thomopoulou
Chem. Lett., 2015
10.
C(7)-Derivatives of colchicine with guanosine and biphenyl moieties: molecular modeling, synthesis, and tubulin clustering effect in cancer cells
11.
The colchicine derivative CT20126 shows a novel microtubule-modulating activity with apoptosis
Kim S., Cho S., Kim H., Seok H., Kim S., Kyu Kwon T., Chang J.
Experimental and Molecular Medicine, 2013
12.
Zefirov N.A., Gadert L., Fatkulin A.R., Shibilev V.M., Butov G.M., Mokhov V.M., Kuznetsov S.A., Zefirova O.N.
Mendeleev Communications, 2020
13.
Adamantyl-substituted ligands of colchicine binding site in tubulin: different effects on microtubule network in cancer cells
14.
A photoaffinity derivative of colchicine: 6'-(4'-azido-2'-nitrophenylamino)hexanoyldeacetylcolchicine. Photolabeling and location of the colchicine-binding site on the alpha-subunit of tubulin.
Williams R.F., Mumford C.L., Williams G.A., Floyd L.J., Aivaliotis M.J., Martinez R.A., Robinson A.K., Barnes L.D.
Journal of Biological Chemistry, 1985
15.
Synthesis and biological evaluation of novel thiocolchicine–podophyllotoxin conjugates
Passarella D., Peretto B., Blasco y Yepes R., Cappelletti G., Cartelli D., Ronchi C., Snaith J., Fontana G., Danieli B., Borlak J.
European Journal of Medicinal Chemistry, 2010
17.
Colchicine poisoning: the dark side of an ancient drug
Finkelstein Y., Aks S.E., Hutson J.R., Juurlink D.N., Nguyen P., Dubnov-Raz G., Pollak U., Koren G., Bentur Y.
Clinical Toxicology, 2010
18.
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
19.
Colchicine Alkaloids and Synthetic Analogues: Current Progress and Perspectives
Gracheva I.A., Shchegravina E.S., Schmalz H., Beletskaya I.P., Fedorov A.Y.
Journal of Medicinal Chemistry, 2020
20.
Colchicine prodrugs and codrugs: Chemistry and bioactivities
Ghawanmeh A.A., Chong K.F., Sarkar S.M., Bakar M.A., Othaman R., Khalid R.M.
European Journal of Medicinal Chemistry, 2018
21.
A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
Crielaard B.J., van der Wal, Lammers, Le, Hennink, Schiffelers R., Storm, Fens
International Journal of Nanomedicine, 2011
23.
Evdokimova A.V., Alexeev A.A., Nurieva E.V., Milaeva E.R., Kuznetsov S.A., Zefirova O.N.
Mendeleev Communications, 2021
24.
Nurieva E.V., Trofimova T.P., Alexeev A.A., Proshin A.N., Chesnakova E.A., Grishin Y.K., Lyssenko K.A., Filimonova M.V., Bachurin S.O., Zefirova O.N.
Mendeleev Communications, 2018
25.
Simple and Efficient Conversion of Colchicine into Deacetylcolchicine
Lebeau L., Ducray P., Mioskowski C.
Synthetic Communications, 1997
26.
Synthesis and Characterization of a Cobalamin−Colchicine Conjugate as a Novel Tumor-Targeted Cytotoxin
Bagnato J.D., Eilers A.L., Horton R.A., Grissom C.B.
Journal of Organic Chemistry, 2004
27.
Zefirov N.A., Evteeva Y.A., Krasnoperova A.I., Mamaeva A.V., Milaeva E.R., Kuznetsov S.A., Zefirova O.N.
Mendeleev Communications, 2020
28.
Novel analogs of 5-hydroxymethyl-2-methoxyphenyl adamantane-1-acetate: synthesis, biotesting, and molecular modeling
Zefirov N.A., Mamaeva A.V., Krasnoperova A.I., Evteeva Y.A., Milaeva E.R., Kuznetsov S.A., Zefirova O.N.
Russian Chemical Bulletin, 2021